Laverdia-CA1 Tablets (Verdinexor) for Dog Cancer Treatment - 50mg

Laverdia-CA1 Tablets for Dog Cancer Treatment

Laverdia-CA1 50mg (Verdinexor) is a revolutionary oral cancer therapy specifically formulated for treating canine lymphoma. Designed to inhibit the export of proteins responsible for tumor progression, Laverdia-CA1 offers a less invasive alternative to traditional chemotherapy. 

This product improves quality of life by allowing owners to administer treatment at home with fewer side effects, making it a convenient choice for pet owners and veterinarians.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.

Benefits of Laverdia-CA1 Tablets

• At-home administration: Oral treatment minimizes stressful vet visits.
• Selective treatment: Targets lymphoma cells while preserving healthy ones.
• Improved tolerance: Fewer side effects than standard chemotherapy, promoting better well-being.
• Flexible integration: This can be combined with other therapies like chemotherapy or radiation.
• Convenient schedule: Administered only twice weekly, reducing the frequency of medication.
• Enhanced survival time: Inhibits cancer cell growth, extending the dog’s quality of life expectancy.

Subscription and Purchase Information

Buying Options and Discounts: Purchase Laverdia-CA1 in a convenient 3-week, 1, 2, 3, and 6-month supply pack. Subscribe for regular shipments to ensure you never miss a dose and enjoy discounts on your purchases.

Order online for hassle-free delivery to your doorstep.

Ingredients

• Primary Ingredient: Verdinexor (50mg)
• Secondary Ingredients: Microcrystalline cellulose, sodium starch glycolate, magnesium stearate, stearic acid

How Does Laverdia-CA1 Work?

Laverdia-CA1 (Verdinexor) is a Selective Inhibitor of Nuclear Export (SINE), which blocks the transport of tumor-suppressing proteins from the nucleus of cells. By doing so, it enhances the body's ability to regulate cell growth and prevent cancer cells from replicating, slowing the progression of lymphoma in dogs.

Dosage and Administration

Always consult your veterinarian for exact dosage instructions depending on your pet’s condition. 

Consistency

For optimal results, administer the medication consistently on the days recommended by your vet. Missing or delaying doses may affect the treatment's efficacy.

Side Effects of Laverdia-CA1 Tablets

While Laverdia-CA1 is generally well-tolerated, some dogs may experience side effects such as:

• Nausea
• Vomiting
• Loss of appetite
• Fatigue
• Weight loss

If your pet shows severe reactions, contact your veterinarian immediately.

Precautions

• Pregnancy: Not safe for use in pregnant or breeding dogs.
• Handling: Avoid contact with broken skin or mucous membranes; wash hands after administering.
• Other Medications: Inform your vet about any other medications your dog is taking to prevent potential interactions.

Warnings

• Keep out of reach of children and other pets.
• Not for use in dogs under 5 lbs.
• Consult a vet if your dog is immunocompromised or has pre-existing liver or kidney conditions.

Storage

• Store Laverdia-CA1 tablets in a cool, dry place, away from direct sunlight.
• Keep the medication in its original packaging, ensuring it is out of the reach of children and pets.
• Avoid storing in humid environments such as bathrooms.

Shipping & Returns 

Shipping Policy: We offer all types of shipping options (Ground, Express, Priority, International) depending on the urgency of the product requirements. To know about our shipping policy in detail, click here.

Refund policy: If you face any issue with our product and want to return it, read our refund policy carefully.

FAQs - Laverdia-CA1 Tablets 

Q: What is Laverdia-CA1 tablets used for?

A: Laverdia-CA1 tablets is used to treat lymphoma in dogs by inhibiting the export of tumor-suppressing proteins, helping to slow the progression of cancer cells and manage the disease more effectively.

Q: How long will my dog need to take Laverdia-CA1 tablets ?

A: The treatment duration depends on the stage of the lymphoma and your dog's response. Some dogs may require long-term administration, while others may have shorter treatment periods. Always follow your vet’s guidance.

Q: Can Laverdia-CA1 tablets be used with other cancer treatments?

A: Yes, Laverdia-CA1 tablets can be combined with chemotherapy, radiation, or other therapies. Your vet will recommend the best treatment plan based on your dog’s condition.

Q: Is Laverdia-CA1 safe for long-term use?

A: Laverdia-CA1 is generally well-tolerated for long-term use in dogs with lymphoma, but regular monitoring by your veterinarian is essential to manage any potential side effects and adjust the dosage if necessary.

Q: Does Laverdia-CA1 require any special storage conditions?

A: Yes, Laverdia-CA1 should be stored in a cool, dry place, away from moisture and direct sunlight. Always keep it out of reach of children and pets.

Q: Can Laverdia-CA1 be given to dogs with other health conditions?

A: Dogs with certain pre-existing conditions, like liver or kidney issues, should be carefully monitored when taking Laverdia-CA1. Always discuss your pet’s health history with your vet before starting treatment.

Q: What should I do if I miss giving a dose of Laverdia-CA1?

A: If you miss a dose, give it as soon as possible unless it is close to the time for the next scheduled dose. Do not double the dose to make up for a missed one. If you're unsure, consult your vet.

Q: Are there any food restrictions while my dog is on Laverdia-CA1?

A: Laverdia-CA1 can be given with or without food, but giving it with a small meal or treat may help prevent nausea. Your veterinarian can offer more specific advice based on your dog's dietary needs.

Q: How soon will I see results after starting Laverdia-CA1?

A: Results vary based on the stage of lymphoma and the individual dog's response to treatment. Some owners report improvements in energy and quality of life within a few weeks.

Q: What should I do if my dog shows side effects from Laverdia-CA1?

A: Contact your veterinarian immediately if your dog experiences side effects such as vomiting, loss of appetite, or severe lethargy. They may adjust the dosage or offer supportive care.

Clinical Researches: 

https://avmajournals.avma.org/view/journals/javma/260/12/javma.22.05.0205.xml

http://www.apvc.ca/notes/2024Vet/Ettinger1WhatsnewinCancerlookahead.pdf